Finance

Lists
AKBA:NASDAQ
Akebia Therapeutics Inc
0,86 US$
-0,69%
(-0,0060) 1D
0,86 US$
-0,46% (-0,0040)
After hours
Closed: 2 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AKBA...
Open
0,89 US$
High
0,89 US$
Low
0,84 US$
Mkt. cap
239,97 მლნ.
Avg. vol.
8,09 მლნ.
Volume
7,11 მლნ.
52-wk high
3,18 US$
52-wk low
0,81 US$
EPS
-0,11 US$
Beta
0,18
Shares outstanding
277,11 მლნ.
No. of employees
194
Open
0,89 US$
High
0,89 US$
Low
0,84 US$
Mkt. cap
239,97 მლნ.
Avg. vol.
8,09 მლნ.
Volume
7,11 მლნ.
52-wk high
3,18 US$
52-wk low
0,81 US$
EPS
-0,11 US$
Beta
0,18
Shares outstanding
277,11 მლნ.
No. of employees
194
News stories
From web sources and news partners
About Akebia Therapeutics Inc
CEO-
Employees194
Founded1 იან. 2007
Headquartersკემბრიჯი, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websiteakebia.com
Analyst ratings
Based on 5 analysts giving stock ratings to AKBA in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for AKBA in the last 3 months.
Highest
Current 0,86 US$
6,00 US$ (+593,64%)
Average
3,90 US$ (+350,87%)
Lowest
1,00 US$ (+15,61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Julian Harrison
BTIG
Buy
Maintained
4,00 US$
+362,4%
09/14/2026
Ed Arce
Westpark Capital
Buy
Initiated
4,50 US$
+420,2%
09/08/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
4,00 US$
+362,4%
08/17/2026
Roanna Ruiz
Leerink Partners
Hold
Downgraded
1,00 US$
+15,6%
08/07/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
6,00 US$
+593,6%
08/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
58,77 მლნ.
57,62 მლნ.
53,54 მლნ.
49,13 მლნ.
Cost of goods sold
10,28 მლნ.
10,93 მლნ.
9,78 მლნ.
9,58 მლნ.
Cost of revenue
10,28 მლნ.
10,93 მლნ.
9,78 მლნ.
9,58 მლნ.
Research and development expenses
14,94 მლნ.
26,65 მლნ.
14,81 მლნ.
14,06 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,09 მლნ.
26,09 მლნ.
30,44 მლნ.
28,17 მლნ.
Operating expense
44,04 მლნ.
52,74 მლნ.
45,24 მლნ.
42,23 მლნ.
Total operating expenses
54,32 მლნ.
63,67 მლნ.
55,02 მლნ.
51,81 მლნ.
Operating income
4,45 მლნ.
-6,05 მლნ.
-1,48 მლნ.
-2,68 მლნ.
Other non operating income
1,45 მლნ.
2,14 მლნ.
459,00 ათ.
559,00 ათ.
EBT including unusual items
1,16 მლნ.
-11,24 მლნ.
-8,93 მლნ.
-8,84 მლნ.
EBT excluding unusual items
1,16 მლნ.
-8,73 მლნ.
-5,71 მლნ.
-5,19 მლნ.
Income tax expense
615,00 ათ.
1,01 მლნ.
126,00 ათ.
70,00 ათ.
Effective tax rate
53,25%
-8,98%
-1,41%
-0,79%
Other operating expenses
-
-
-
-
Net income
540,00 ათ.
-12,24 მლნ.
-9,05 მლნ.
-8,91 მლნ.
Net profit margin
0,92%
-21,25%
-16,91%
-18,13%
Earnings per share
-
-0,05
-0,03
-0,03
Interest and investment income
-
-
-
-
Interest expense
-4,75 მლნ.
-4,83 მლნ.
-4,69 მლნ.
-3,07 მლნ.
Net interest expenses
-4,75 მლნ.
-4,83 მლნ.
-4,69 მლნ.
-3,07 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
4,77 მლნ.
-5,73 მლნ.
-1,15 მლნ.
-2,10 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები